Results 141 to 150 of about 40,886,999 (373)

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

Proyectos de investigación científica en salud

open access: yesRevista Electrónica Dr. Zoilo E. Marinello Vidaurreta, 2016
El proceso de investigación científica nace a partir de la necesidad de resolver un déficit cognitivo existente en el objeto de estudio, transita por diferentes etapas, condicionadas por factores objetivos y subjetivos.
Elso Manuel Cruz Cruz
doaj  

The Process of Developing a Digital Repository for Online Teaching Using Design-Based Research [PDF]

open access: hybrid, 2022
Jennifer Richardson   +3 more
openalex   +1 more source

Dimensions of design space: a decision-theoretic approach to optimal research design [PDF]

open access: yes
Bayesian decision theory can be used not only to establish the optimal sample size and its allocation in a single clinical study, but also to identify an optimal portfolio of research combining different types of study design.
Karl Claxton, Stefano Conti
core  

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

open access: yesMolecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié   +16 more
wiley   +1 more source

Rayuela 2.0: Una herramienta para promocionar la labor innovadora de maestros y maestras mediante la generación de diseños de investigación rigurosos / Hopscotch 2.0: A tool to promote teachers’ innovative work through the generation of rigorous research designs

open access: yesRevista Latinoamericana de Tecnología Educativa, 2019
En este artículo presentamos Rayuela 2.0, un marco teórico y una herramienta web pensados para ayudar a investigadores noveles en educación y ciencias sociales, en la generación de diseños de investigación sólidos y bien informados.
Iván Manuel Jorrín-Abellán
doaj   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy